Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Alan Meds vs Go Vida Plena

Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, Go Vida Plena a 68. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Alan Meds

#7 · Grade A · Best Value

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Alan Meds review →
VS

Go Vida Plena

#277 · Grade C · Watch List

Est. first month

From $199/mo (starting dose, compounded)

Save ~85% vs brand-name
Get this deal Full Go Vida Plena review →

The verdict

Better value: Alan Meds

Alan Meds takes it on Value Score, 90 to 68 an est. $99/mo first month, with no teaser step-up baked in. Go Vida Plena isn't out of it: Shoppers who want spanish-speaking patients wanting a bilingual, Latino-food-friendly GLP-1 program from $199/mo.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealAlan MedsGo Vida Plena
Value Score90 (A)68 (C)
Est. first month$99/moFrom $199/mo (starting dose, compounded)
Save vs brand-name~93%~85%
Semaglutide$99/moFrom $199/mo (starting dose, compounded)
Tirzepatide$145/moFrom $269/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
72
Alan Meds: 95. Go Vida Plena: 72.
85
No Teaser-Rate Bait
64
Alan Meds: 85. Go Vida Plena: 64.
98
Nationwide Availability
45
Alan Meds: 98. Go Vida Plena: 45.
94
Both Molecules
98
Alan Meds: 94. Go Vida Plena: 98.
82
Easy Cancellation
58
Alan Meds: 82. Go Vida Plena: 58.
72
Reputation
63
Alan Meds: 72. Go Vida Plena: 63.

Alan Meds

Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.

Why it's a deal

  • $99 flat semaglutide and a low $145 tirzepatide
  • Available in all 50 states
  • Offers an oral/sublingual route

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Newer operator with a thin public track record

Go Vida Plena

Go Vida Plena is a Spanish-first, Latino-focused medical weight-loss program offering GLP-1 therapy from $199/month, based in Utah.

Why it's a deal

  • Spanish-first, fully bilingual GLP-1 program tailored to Latino food and lifestyle - a genuinely underserved niche
  • Compounded semaglutide, tirzepatide, and oral semaglutide from $199/mo, with installment pay (Klarna, Afterpay, Affirm)
  • Free initial consultation; medications shipped discreetly to your door after a medical evaluation
  • Includes 24/7 support, 4 virtual visits a year, and ongoing nutrition coaching
  • Physician-supervised program (Utah medical backing) with continuous follow-up

The fine print

  • Utah-based, and the full list of states served is not published
  • Only a '$199/mo starting' price is shown upfront; tirzepatide and oral-semaglutide pricing isn't published
  • The compounding pharmacy is not named (a 'provider pharmacies' page exists but lists no name)
  • Compounded GLP-1 medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • No LegitScript certification displayed
Get the Alan Meds deal Get the Go Vida Plena deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to Go Vida Plena.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.